{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:11:55Z","timestamp":1790190715331,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"9","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.humimm.2013.06.020","type":"journal-article","created":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T19:50:17Z","timestamp":1371585017000},"page":"1184-1193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Autoimmune associations and autoantibody screening show focused recognition in patient subgroups with generalized myasthenia gravis"],"prefix":"10.1016","volume":"74","author":[{"given":"Reinhild","family":"Klein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Str\u00f6bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berthold","family":"Schalke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfred","family":"Nix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Willcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2013.06.020_b0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaut.2009.09.008","article-title":"Recent insights in the epidemiology of autoimmune diseases: improved estimates and understanding of clustering of diseases","volume":"33","author":"Cooper","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.humimm.2013.06.020_b0010","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/brain\/81.1.112","article-title":"An evaluation of thymectomy in myasthenia gravis","volume":"81","author":"Simpson","year":"1958","journal-title":"Brain"},{"key":"10.1016\/j.humimm.2013.06.020_b0015","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/003693306000501001","article-title":"Myasthenia gravis; a new hypothesis","volume":"5","author":"Simpson","year":"1960","journal-title":"Scott Med J"},{"key":"10.1016\/j.humimm.2013.06.020_b0020","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1749-6632.1987.tb51301.x","article-title":"The membrane attack complex of complement at the endplate in myasthenia gravis","volume":"505","author":"Engel","year":"1987","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.humimm.2013.06.020_b0025","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","article-title":"Myasthenia gravis","volume":"357","author":"Vincent","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2013.06.020_b0030","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1749-6632.1966.tb45499.x","article-title":"Myasthenia gravis as an autoimmune disease: clinical aspects","volume":"135","author":"Simpson","year":"1966","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.humimm.2013.06.020_b0035","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates and diagnostic value","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology"},{"key":"10.1016\/j.humimm.2013.06.020_b0040","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/jnnp.48.12.1246","article-title":"Acetylcholine receptor antibody as a diagnostic test for myastenia gravis: results in 153 validated cases and 2967 diagnostic assays","volume":"48","author":"Vincent","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.humimm.2013.06.020_b0045","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1196\/annals.1405.040","article-title":"Myasthenia gravis in the elderly: is it different?","volume":"1132","author":"Aarli","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.humimm.2013.06.020_b0050","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/brain\/103.3.579","article-title":"Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis","volume":"103","author":"Compston","year":"1980","journal-title":"Brain"},{"key":"10.1016\/j.humimm.2013.06.020_b0055","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1196\/annals.1405.027","article-title":"Genetic factors in autoimmune myasthenia gravis","volume":"1132","author":"Giraud","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.humimm.2013.06.020_b0060","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0198-8859(99)00062-2","article-title":"A susceptibility region for myasthenia gravis extending into the HLA-class I sector telomeric to HLA-C","volume":"60","author":"Janer","year":"1999","journal-title":"Hum Immunol"},{"key":"10.1016\/j.humimm.2013.06.020_b0065","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.57.9.1555","article-title":"Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodies","volume":"57","author":"Giraud","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.humimm.2013.06.020_b0070","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ana.23691","article-title":"Risk for myasthenia gravis maps to (151) Pro-Ala change in TNIP1 and to human leukocyte antigen-B\u221708","volume":"72","author":"Gregersen","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.humimm.2013.06.020_b0075","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ana.1017","article-title":"Mature, long-lived CD4(+) and CD8(+) T cells are generated by the thymoma in myasthenia gravis","volume":"50","author":"Buckley","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.humimm.2013.06.020_b0080","first-page":"447","article-title":"Myasthenic and nonmyasthenic thymoma \u2013 an expansion of a minor cortical epithelial-cell subset","volume":"127","author":"Willcox","year":"1987","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humimm.2013.06.020_b0085","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/08916930903555935","article-title":"Thymoma and paraneoplastic myasthenia gravis","volume":"43","author":"Marx","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.humimm.2013.06.020_b0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-2249.2000.01256.x","article-title":"Altered T cell development in human thymoma is related to impairment of MHC class II transactivator expression induced by interferon-gamma (IFN-gamma)","volume":"121","author":"Kadota","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.humimm.2013.06.020_b0095","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1196\/annals.1405.021","article-title":"Autoimmunizing mechanisms in thymoma and thymus","volume":"1132","author":"Willcox","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.humimm.2013.06.020_b0100","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/path.2141","article-title":"Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type I (APS-I)","volume":"211","author":"Str\u00f6bel","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humimm.2013.06.020_b0105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.immunol.25.022106.141532","article-title":"Aire","volume":"27","author":"Mathis","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.humimm.2013.06.020_b0110","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2796.2009.02090.x","article-title":"Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I","volume":"265","author":"Husebye","year":"2009","journal-title":"J Intern Med"},{"key":"10.1016\/j.humimm.2013.06.020_b0115","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1210\/jc.2005-2611","article-title":"Extensive clinical experience \u2013 Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy","volume":"91","author":"Perheentupa","year":"2006","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.humimm.2013.06.020_b0120","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20091669","article-title":"Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines","volume":"207","author":"Kisand","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.humimm.2013.06.020_b0125","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1084\/jem.20091983","article-title":"Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I","volume":"207","author":"Puel","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.humimm.2013.06.020_b0130","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/archinte.1974.00320200184029","article-title":"The spectrum of diseases associated with thymoma. Coincidence or syndrome?","volume":"134","author":"Souadjian","year":"1974","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.humimm.2013.06.020_b0135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0404.2006.00608.x","article-title":"Titin and ryanodine receptor antibodies in myasthenia gravis","volume":"113","author":"Skeie","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.humimm.2013.06.020_b0140","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1365-2249.2003.02113.x","article-title":"Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and\/or myasthenia gravis","volume":"132","author":"Meager","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.humimm.2013.06.020_b0145","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.1.5899.131","article-title":"Myasthenia gravis, autoantibodies and HL-A antigen","volume":"26","author":"Feltkamp","year":"1974","journal-title":"Br Med J"},{"key":"10.1016\/j.humimm.2013.06.020_b0150","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/BF01488718","article-title":"Myasthenia gravis: overlap with \u2018polyendocrine\u2019 autoimmunity","volume":"61","author":"Scherbaum","year":"1983","journal-title":"Klin Woschenschr"},{"key":"10.1016\/j.humimm.2013.06.020_b0155","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1016\/j.febslet.2011.04.032","article-title":"Why is PTPN22 a good candidate susceptibility gene for autoimmune disease?","volume":"585","author":"Burn","year":"2011","journal-title":"FEBS Lett"},{"key":"10.1016\/j.humimm.2013.06.020_b0160","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3109\/08916930903518073","article-title":"The auto-antigen repertoire in myasthenia gravis","volume":"43","author":"Vrolix","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.humimm.2013.06.020_b0165","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1177\/000348948909800708","article-title":"High antibody-levels against mouse laminin with specificity for galactosyl-(alpha-1-3)galactose in patients with inner-ear diseases","volume":"98","author":"Klein","year":"1989","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.humimm.2013.06.020_b0170","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0022-1759(98)00074-X","article-title":"Self-reactive antibodies (natural autoantibodies) in healthy individuals","volume":"216","author":"Lacroix-Desmazes","year":"1998","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.humimm.2013.06.020_b0175","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s10875-011-9617-4","article-title":"Radioligand-binding assay reveals distinct autoantibody preferences for Type I interferons in APS I and myasthenia gravis subgroups","volume":"32","author":"Hapnes","year":"2012","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.humimm.2013.06.020_b0180","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.126.2.277","article-title":"Mitochondrial antibodies in primary biliary cirrhosis. I. Localization of the antigen to mitochondrial membranes","volume":"126","author":"Berg","year":"1967","journal-title":"J Exp Med"},{"key":"10.1016\/j.humimm.2013.06.020_b0185","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2265.1982.tb00726.x","article-title":"Development of adrenocortical failure in non-Addisonian patients with antibodies to adrenal cortex","volume":"16","author":"Scherbaum","year":"1982","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.humimm.2013.06.020_b0190","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1586\/erm.11.82","article-title":"Antinuclear antibodies as ancillary markers in primary biliary cirrhosis","volume":"12","author":"Granito","year":"2012","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.humimm.2013.06.020_b0195","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/hep.1840140632","article-title":"Significance and specificity of antibodies to neutrophils detected by western blotting for the serological diagnosis of primary sclerosing cholangitis","volume":"14","author":"Klein","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.humimm.2013.06.020_b0200","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(94)80002-2","article-title":"Induction of autoimmune phenomena in patients with chronic hepatitis B treated with gamma-interferon","volume":"20","author":"Weber","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.humimm.2013.06.020_b0205","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-0676.1997.tb00793.x","article-title":"Antimitochondrial antibody profiles in primary biliary cirrhosis distinguish at early stages between a benign and a progressive course: a prospective study on 200 patients followed for 10years","volume":"17","author":"Klein","year":"1997","journal-title":"Liver"},{"key":"10.1016\/j.humimm.2013.06.020_b0210","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1046\/j.1365-2249.1999.01027.x","article-title":"Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and navel peptide epitopes","volume":"118","author":"Klein","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.humimm.2013.06.020_b0215","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.humimm.2013.06.020_b0220","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1212\/WNL.0b013e31825644ff","article-title":"Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients","volume":"78","author":"Leite","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.humimm.2013.06.020_b0225","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/ng.480","article-title":"Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis","volume":"41","author":"Mahdi","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.humimm.2013.06.020_b0230","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1196\/annals.1254.022","article-title":"Autoimmune disorders of neuronal potassium channels, myasthenia gravis and related disorders","volume":"998","author":"Newsom-Davis","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.humimm.2013.06.020_b0235","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/brain\/123.6.1102","article-title":"Autoimmune disease in first-degree relatives of patients with multiple sclerosis. A UK survey","volume":"123","author":"Broadley","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.humimm.2013.06.020_b0240","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1615\/CritRevImmunol.v31.i3.10","article-title":"The contribution of thymic stromal abnormalities to autoimmune disease","volume":"31","author":"Fletcher","year":"2011","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.humimm.2013.06.020_b0245","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s00018-012-0970-0","article-title":"Immune aging and autoimmunity","volume":"69","author":"Goronzy","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.humimm.2013.06.020_b0250","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00281-010-0201-4","article-title":"Lymphoid tyrosine phosphatase and autoimmunity: human genetics rediscovers phosphatases","volume":"32","author":"Stanford","year":"2010","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.humimm.2013.06.020_b0255","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1007\/s00415-011-6335-z","article-title":"The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases with a special focus on hydroxychloroquine use and a review of the literature","volume":"259","author":"Jallouli","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.humimm.2013.06.020_b0260","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S1474-4422(07)70132-1","article-title":"Autoimmune disease in families with multiple sclerosis: a population-based study","volume":"6","author":"Ramagopalan","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.humimm.2013.06.020_b0265","doi-asserted-by":"crossref","first-page":"e32487","DOI":"10.1371\/journal.pone.0032487","article-title":"Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity","volume":"7","author":"Sardu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2013.06.020_b0270","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jneuroim.2009.08.018","article-title":"Expanded TCR V beta subsets of CD8(+) T-cells in late-onset myasthenia gravis: Novel parallels with thymoma patients","volume":"216","author":"Tackenberg","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.humimm.2013.06.020_b0275","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1474-4422(03)00663-X","article-title":"Genetics of multiple sclerosis","volume":"3","author":"Dyment","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.humimm.2013.06.020_b0280","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/ng1647","article-title":"A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis","volume":"37","author":"Lincoln","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.humimm.2013.06.020_b0285","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0165-5728(02)00145-5","article-title":"Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules","volume":"128","author":"Romi","year":"2002","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.humimm.2013.06.020_b0290","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.humimm.2011.12.022","article-title":"High prevalence of infections and autoimmunity in patients with thymoma","volume":"73","author":"Holbro","year":"2012","journal-title":"Hum Immunol"},{"key":"10.1016\/j.humimm.2013.06.020_b0295","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.rdc.2004.04.012","article-title":"Altered structure of autoantigens during apoptosis","volume":"30","author":"Hall","year":"2004","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.humimm.2013.06.020_b0300","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1191\/096120300678828055","article-title":"Thymoma associated with systemic lupus erythematosus and immunologic abnormalities","volume":"9","author":"Bozzolo","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.humimm.2013.06.020_b0305","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/eji.201041253","article-title":"Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: clinical and pathogenetic implications","volume":"41","author":"Kisand","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.humimm.2013.06.020_b0310","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-065X.2011.01008.x","article-title":"Control of central and peripheral tolerance by Aire","volume":"241","author":"Metzger","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.humimm.2013.06.020_b0315","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.autrev.2012.02.006","article-title":"Intravenous immunoglobulin: exploiting the potential of natural antibodies","volume":"11","author":"Kaveri","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.humimm.2013.06.020_b0320","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0168-8278(88)80046-1","article-title":"Demonstration of \u201cNaturally occurring mitochondrial antibodies\u201d in family members of patients with primary biliary cirrhosis","volume":"6","author":"Klein","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.humimm.2013.06.020_b0325","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/871401","article-title":"Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection","author":"Himoto","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.humimm.2013.06.020_b0330","doi-asserted-by":"crossref","first-page":"A259","DOI":"10.1016\/j.autrev.2009.12.002","article-title":"Definition of human autoimmunity - autoantibodies versus autoimmune disease","volume":"9","author":"Lleo","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.humimm.2013.06.020_b0335","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1753-0407.2010.00102.x","article-title":"Prediction and prevention of Type 1 diabetes mellitus","volume":"3","author":"Zhang","year":"2011","journal-title":"J Diabetes"},{"key":"10.1016\/j.humimm.2013.06.020_b0340","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1212\/WNL.58.10.1563","article-title":"Myasthenia gravis in a woman with congenital AChR deficiency due to epsilon-subunit mutations","volume":"58","author":"Croxen","year":"2002","journal-title":"Neurology"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885913001778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885913001778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T20:34:35Z","timestamp":1563222875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885913001778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":68,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0198885913001778"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2013.06.020","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune associations and autoantibody screening show focused recognition in patient subgroups with generalized myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2013.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}